GlassScriptPhysician profile
Yvonne Wang
NPI 1679953863
$2,352.92
in general payments reported to CMS, 2019-2025
9 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $177 · 2021: $331 · 2023: $1,186 · 2024: $78.54 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $796 · Food and Beverage: $795 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $796.15 |
| Food and Beverage | $795.13 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $918.81 | 2019-2023 | Clareon |
| Glaukos Corporation | $692.77 | 2020-2025 | Photrexa Viscous and Photrexa, Ce-Marked Kxla System, Photrexa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $217.49 | 2019 | |
| Dompe US, INC. | $140.44 | 2021 | |
| Rxsight INC | $135.17 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Celularity INC. | $96.78 | 2021 | |
| Oyster Point Pharma, INC. | $77.41 | 2023 | Tyrvaya |
| Carl Zeiss Meditec USA, INC. | $56.21 | 2023 | |
| Bausch & Lomb Americas INC. | $17.84 | 2023 | Miebo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvonne Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.